Nutriband Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Nutriband Inc. (Nasdaq: NTRB) on January 3, 2022, covering the event date of December 31, 2021. The company is incorporated in Nevada and operates as an emerging growth company. Its principal executive offices are located in Orlando, Florida.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a regulatory disclosure event rather than financial performance data.
Material Changes
On December 31, 2021, the Korean Intellectual Property Office issued a patent to the Company titled "Abuse and Misuse Deterrent Transdermal System." This patent is directly related to the Company's lead technology, AVERSA™.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of the patent issuance. The event is reported under Item 7.01 (Regulation FD Disclosure) and includes a press release as Exhibit 99.1.
Investor Verification Checklist
- Verify the scope and enforceability of the newly issued Korean patent for the AVERSA™ technology.
- Review the attached Press Release (Exhibit 99.1) for details on the commercial implications of the patent.
- Confirm the status of the Company's common stock (NTRB) and warrants (NTRBW) on The Nasdaq Stock Market LLC.
- Check subsequent filings for any financial impact or milestones related to this intellectual property development.